 |
1,2:5,6-Dianhdrogalactitol, NSC-132313 |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant gliomas |
| USA Market Approval | USA |
| USA Designation Date | 2012-01-31 00:00:00 |
| Sponsor | DelMar Pharmaceuticals, Inc.;3475 Edison Way, Suite R;Menlo Park, California, 94025 |
| |
1,2:5,6-Dianhdrogalactitol, NSC-132313 |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant gliomas |
| USA Market Approval | USA |
| USA Designation Date | 2012-01-31 00:00:00 |
| Sponsor | DelMar Pharmaceuticals, Inc.;3475 Edison Way, Suite R;Menlo Park, California, 94025 |